Clinical trials: Iliofemoral Venous Thrombosis
Thrombolysis, Deep Vein Thrombosis
Contemporary Endovascular Therapies in Treatment of Acute Iliofemoral Deep Vein Thrombosis
The goal of this initial proof of principle single arm cohort trial is to determine if contemporary endovascular venous intervention, compared with a 1:1 propensity-matched medical therapy arm of the ATTRACT trial, significantly…
- Trial name
- CLEAR-DVT (NCT03901872)
- Testing
- Contemporary endovascular venous intervention by Zelante pharmacomechanical thrombolysis
- Where
- United Kingdom
- Volunteers
- 65 people
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
Deep Vein Thrombosis of the Lower Extremities
AI-Based Prediction Model for Iliofemoral DVT Thrombolysis
This prospective single-arm cohort study aims to develop an AI-powered prediction model for treatment outcomes in patients with acute extensive iliofemoral deep vein thrombosis (IF-DVT) undergoing stent-free pharmacomechanical…
- Trial name
- NCT07181083
- Testing
- Rheolytic thrombectomy
- Where
- Iran
- Volunteers
- 30 people
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
Acute Thrombosis of Deep Veins of Proximal Lower Extremity
DUTCH CAVA-trial: CAtheter Versus Anticoagulation Alone for Acute Primary (Ilio)Femoral DVT.
Rationale: Iliofemoral deep venous thrombosis (IFDVT) is associated with significant post thrombotic morbidity. The presence of both obstruction and reflux significantly increases the chances for development of post-thrombotic…
- Trial name
- NL28394 (NCT00970619)
- Testing
- Ekos endowave system thrombolysis
- Where
- 16 sites in Netherlands
- Volunteers
- 184 people
- Sponsor
- Maastricht University Medical Center
Ileofemoral Deep Vein Thrombosis
Prevention of Recurrence After Thrombolysis in Acute Iliofemoral Venous Thrombosis (PRAIS) Study
The EINSTEIN program showed that oral rivaroxaban is effective and safe treatment for prevention of recurrent venous thrombosis and pulmonary embolism in deep vein thrombosis patients and FDA approved the rivaroxaban for…
- Trial name
- PRAIS (NCT01986192)
- Testing
- rivaroxaban, Warfarin
- Where
- South Korea
- Volunteers
- 72 people
- Sponsor
- Seoul National University Hospital
Iliac Vein Thrombosis
Substudy - Evaluation of Patients With Iliac Vein Thrombosis
Patients with previous diagnosis of iliac vein thrombosis are enrolled in this registry. Using standardized questionnaire, clinical data detailing venous thromboembolism and contributing VTE risk factors are recorded.
- Trial name
- NCT03148548
- Testing
- thrombophilia screening
- Where
- Germany
- Volunteers
- 85 people
- Sponsor
- Cardioangiologisches Centrum Bethanien